English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  50569069    Online Users :  886
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 345826-345850 of 2347236  (93890 Page(s) Totally)
<< < 13829 13830 13831 13832 13833 13834 13835 13836 13837 13838 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2008 Durumolides A–E, anti-inflammatory and antibacterial cembranolides from the soft coral Lobophytum durum Duh, Chang-Yih; Chiang, Michael Y.; Dai, Chang-Feng; Wang, Shang-Kewi; Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin; Wang, Shang-Kewi; Dai, Chang-Feng; Chiang, Michael Y.; Duh, Chang-Yih; Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin
臺大學術典藏 2020-05-26T09:26:29Z Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Havel L; Pauk N; Singh J; Murakami S; Garassino M.C; Cho B.-C; Kim J.-H; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray J.E; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo R.A; Huang Y; Wadsworth C; Dennis P.A; Rizvi N.A; Paz-Ares Rodriguez L; Novello S; Hiret S; Schmid P; Laack E; Califano R; Maemondo M; Kim S.-W; Chaft J; Vicente Baz D; Berghmans T; Kim D.-W; Surmont V; Reck M; Han J.-Y; Holgado Martin E; Belda Iniesta C; Oe Y; Chella A; Chopra A; Robinet G; Soto Parra H; Thomas M; Cheema P; Katakami N; Su W.-C; Kim Y.-C; Wolf J; Lee J.-S; Saka H; Milella M; Ramos Garcia I; Sibille A; Yokoi T; Kang E.J; Atagi S; Spaeth-Schwalbe E; Nishio M; Imamura F; Gabrail N; Veillon R; Derijcke S; Maeda T; Zylla D; Kubiak K; Santoro A; Uy M.N; Lucien Geater S; Italiano A; Kowalski D; Barlesi F; Chen Y.-M; Spigel D; Chewaskulyong B; Garcia Gomez R; Alvarez Alvarez R; CHIH-HSIN YANG; Hsia T.-C; Denis F; Sakai H; Vincent M; Goto K; Bosch-Barrera J; Weiss G; Canon J.-L; Scholz C; Aglietta M; Kemmotsu H; Csoszi T; Losonczy G; Price A; Anderson I; Iqbal M; Torri V; Juhasz E; Khanani S; Koubkova L; Levy B; Page R; Bocskei C; Crinò L; Einspahr D; Hagenstad C; Juat N; Overton L; Garrison M; Szalai Z; ATLANTIC Investigators; Azuma K; Bradbury P; Feld R; Chachoua A; Jassem J; Juergens R; Palmero Sanchez R; Malcolm A; Vrindavanam N; Kubota K; Waller C; Waterhouse D; Coudert B; Mark Z; Satouchi M; Chang G.-C; Herzmann C; Chaudhry A; Giridharan S; Hesketh P; Ikeda N; Boccia R; Iannotti N; Haigentz M; Reynolds J; Querol J; Nakagawa K; Sugawara S; Tan E.H; Hirashima T; Gettinger S; Kato T; Takeda K; Juan Vidal O; Mohn-Staudner A; Panwalkar A; Daniel D; Kobayashi K; Ladrera G.E.I; Schulte C; Sebastian M; Cernovska M; Coupkova H; Juat N;Hagenstad C;Einspahr D;Crin? L;Bocskei C;Page R;Levy B;Koubkova L;Khanani S;Juhasz E;Torri V;Iqbal M;Anderson I;Price A;Losonczy G;Csoszi T;Murakami S;Singh J;Pauk N;Havel L;Coupkova H;Cernovska M;Sebastian M;Schulte C;Ladrera G.E.I;Kobayashi K;Daniel D;Panwalkar A;Mohn-Staudner A;Juan Vidal O;Takeda K;Kato T;Gettinger S;Hirashima T;Tan E.H;Sugawara S;Nakagawa K;Querol J;Reynolds J;Haigentz M;Iannotti N;Boccia R;Ikeda N;Hesketh P;Giridharan S;Chaudhry A;Herzmann C;Chang G.-C;Satouchi M;Mark Z;Coudert B;Waterhouse D;Waller C;Kubota K;Vrindavanam N;Malcolm A;Palmero Sanchez R;Juergens R;Jassem J;Chachoua A;Feld R;Bradbury P;Azuma K;Kemmotsu H;Aglietta M;Scholz C;Canon J.-L;Weiss G;Bosch-Barrera J;Goto K;Vincent M;Sakai H;Denis F;Hsia T.-C;Chih-Hsin Yang;Alvarez Alvarez R;Garcia Gomez R;Chewaskulyong B;Spigel D;Chen Y.-M;Barlesi F;Kowalski D;Italiano A;Lucien Geater S;Uy M.N;Santoro A;Kubiak K;Zylla D;Maeda T;Derijcke S;Veillon R;Gabrail N;Imamura F;Nishio M;Spaeth-Schwalbe E;Atagi S;Kang E.J;Yokoi T;Sibille A;Ramos Garcia I;Milella M;Saka H;Lee J.-S;Wolf J;Kim Y.-C;Su W.-C;Katakami N;Atlantic Investigators;Szalai Z;Garrison M;Overton L;Cheema P;Thomas M;Soto Parra H;Robinet G;Chopra A;Chella A;Oe Y;Belda Iniesta C;Holgado Martin E;Han J.-Y;Reck M;Surmont V;Kim D.-W;Berghmans T;Vicente Baz D;Chaft J;Kim S.-W;Maemondo M;Califano R;Laack E;Schmid P;Hiret S;Novello S;Paz-Ares Rodriguez L;Rizvi N.A;Dennis P.A;Wadsworth C;Huang Y;Soo R.A;Park K;Wheatley-Price P;Bidoli P;Chouaid C;Powderly J;Gray J.E;Corral Jaime J;Lena H;Vansteenkiste J;Mazi?res J;Kim J.-H;Cho B.-C;Garassino M.C
國立成功大學 2024-08 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study Oh;Do-Youn;He;Ruth, Aiwu;Bouattour;Mohamed;Okusaka;Takuji;Qin;Shukui;Chen;Li-Tzong;Kitano;Masayuki;Lee;Choong-kun;Kim;Won, Jin;Chen;-Huang, Ming;Suksombooncharoen;Thatthan;Ikeda;Masafumi;Lee;Ah, Myung;Chen;Jen-Shi;Potemski;Piotr;Burris;Howard, A.;Ostwal;Vikas;Tanasanvimon;Suebpong;Morizane;Chigusa;Zaucha;Renata, E.;Mcnamara;Mairead, G.;Avallone;Antonio;Cundom;Juan, E.;Breder;Valeriy;Tan;Benjamin;Shimizu;Satoshi;Tougeron;David;Evesque;Ludovic;Petrova;Mila;Zhen;David, B.;Gillmore;Roopinder;Gupta;Govinda, Vineet;Dayyani;Farshid;Park;Oh, Joon;Jr, Buchschacher;Gary, L.;Rey;Felipe;Kim;Hyosung;Wang;Julie;Morgan;Claire;Rokutanda;Nana;Zotkiewicz;Magdalena;Vogel;Arndt;Valle;Juan, W.
國家衛生研究院 2024-08 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study Oh, DY;He, AR;Bouattour, M;Okusaka, T;Qin, S;Chen, LT;Kitano, M;Lee, CK;Kim, JW;Chen, MH;Suksombooncharoen, T;Ikeda, M;Lee, MA;Chen, JS;Potemski, P;Burris, HA, 3rd;Ostwal, V;Tanasanvimon, S;Morizane, C;Zaucha, RE;McNamara, MG;Avallone, A;Cundom, JE;Breder, V;Tan, B;Shimizu, S;Tougeron, D;Evesque, L;Petrova, M;Zhen, DB;Gillmore, R;Gupta, VG;Dayyani, F;Park, JO;Buchschacher, GL, Jr.;Rey, F;Kim, H;Wang, J;Morgan, C;Rokutanda, N;Żotkiewicz, M;Vogel, A;Valle, JW
國立成功大學 2024 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study Oh;D, -Y.;He;A, R.;Bouattour;M;Okusaka;T;Qin;S;Chen;L, -T.;Kitano;M;Lee;C, -K.;Kim;J, W.;Chen;M, -H.;Suksombooncharoen;T;Ikeda;M;Lee;M, -A.;Chen;J, -S.;Potemski;P;Burris;H, A.;Ostwal;V;Tanasanvimon;S;Morizane;C;Zaucha;R, E.;McNamara;M, G.;Avallone;A;Cundom;J, E.;Breder;V;Tan;B;Shimizu;S;Tougeron;D;Evesque;L;Petrova;M;Zhen;D, B.;Gillmore;R;Gupta;V, G.;Dayyani;F;Park;J, O.;Buchschacher;G, L.;Rey;F;Kim;H;Wang;J;Morgan;C;Rokutanda;N;Żotkiewicz;M;Vogel;A;Valle;J, W.
國家衛生研究院 2025-05-15 Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, R;Avallone, A;Cundom, J;Kuzko, A;Wang, J;Xynos, I;Vogel, A;Valle, JW
國家衛生研究院 2025-02 Durvalumab, tremelimumab, and platinum chemotherapy in EGFR mutation–positive NSCLC: An open-label Phase 2 trial (ILLUMINATE) Lee, CK;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, AJ;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Ford, K;Cummins, MM;Stockler, MR;Solomon, BJ;John, T;Chih-Hsin Yang, J
國立臺灣大學 1993 Dusformone and Dischidiol from Dischida Formosana Chen, Z. S.; Lee, G. H.; 郭悅雄; Chen, Z. S.; Lee, G. H.; Kuo, Yueh-Hsiung
國立成功大學 2013-08-27 dusfusion 在邊境細胞的功能分析 吳榛惟; Wu, Jhen-Wei
國立成功大學 2013-07-19 dusfusion 在邊境細胞的功能分析 吳榛惟; Wu, Jhen-Wei
國立臺灣大學 2015 DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers Lin, Yun-Chieh; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow; 張逸良; 施金元; 陳青周
臺大學術典藏 2018-09-10T15:17:53Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin, Yun-Chieh;Lin, Yu-Chin;Shih, Jin-Yuan;Huang, Wei-Jan;Chao, Shi-Wei;Chang, Yih-Leong;Chen, Ching-Chow; Lin, Y.-C. and Lin, Y.-C. and Shih, J.-Y. and Huang, W.-J. and Chao, S.-W. and Chang, Y.-L. and Chen, C.-C.; 張逸良;施金元;陳青周; YIH-LEONG CHANG; Lin, Yun-Chieh; JIN-YUAN SHIH; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow
臺大學術典藏 2020-03-06T05:26:13Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C.
臺大學術典藏 2020-03-07T06:56:23Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.;Lin Y.-C.;Shih J.-Y.;Huang W.-J.;Chao S.-W.;Yih-Leong Chang;Chen C.-C.; Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C.
臺大學術典藏 2020-08-13T06:33:43Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.; Lin Y.-C.; JIN-YUAN SHIH; Huang W.-J.; Chao S.-W.; Chang Y.-L.; Chen C.-C.
臺大學術典藏 2021-05-07T05:13:26Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; Chang Y.-L.; CHING-CHOW CHEN
國家衛生研究院 2020-08-12 DUSP11 attenuates lipopolysaccharide-induced macrophage activation by targeting TAK1 Yang, CY;Chuang, HC;Tsai, CY;Xiao, YZ;Yang, JY;Huang, RH;Shih, YC;Tan, TH
國家衛生研究院 2020-01 DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination Wang, CA;Chang, IH;Hou, PC;Tai, YJ;Li, WN;Hsu, PL;Wu, SR;Chiu, WT;Li, CF;Shan, YS;Tsai, SJ
國立成功大學 2020-01-1 DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination Wang;Chu-An;Chang;I-Heng;Hou;Pei-Chi;Tai;Yu-Jing;Li;Wan-Ning;Hsu;Pei-Ling;Wu;Shang-Rung;Chiu;Wen-Tai;Li;Chien-Feng;Shan;Yan-Shen;Tsai;Shaw-Jenq
國家衛生研究院 2024-06-14 DUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling Lin, HH;Chang, CW;Liao, YT;Yeh, SD;Lin, HP;Ho, HM;Cheung, CHY;Juan, HF;Chen, YR;Su, YW;Chen, LM;Tan, TH;Lin, WJ
國家衛生研究院 2019-12 DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis Lin, HP;Ho, HM;Chang, CW;Yeh, SD;Su, YW;Tan, TH;Lin, WJ
國立成功大學 2024-08 DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1-immunophenotype Chen;Bo-Jung;Hsieh;Shu-Min;Hsieh;Tsung-Han;Jhuang;Jie-Yang;Kao;Yu-Chien
國立成功大學 2024 DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1− immunophenotype Chen;B, -J.;Hsieh;S, -M.;Hsieh;T, -H.;Jhuang;J, -Y.;Kao;Y, -C.
國家衛生研究院 2022-06-15 DUSP3 regulates phosphorylation-mediated degradation of occludin and is required for maintaining epithelial tight junction Chou, HC;Cheng, CM;Yang, CH;Lin, TY;Liu, YW;Tan, TH;Chen, YR
國家衛生研究院 2012-02 DUSP4 deficiency enhances CD25 expression and CD4(+) T-cell proliferation without impeding T-cell development Huang, CY;Lin, YC;Hsiao, WY;Liao, FH;Huang, PY;Tan, TH

Showing items 345826-345850 of 2347236  (93890 Page(s) Totally)
<< < 13829 13830 13831 13832 13833 13834 13835 13836 13837 13838 > >>
View [10|25|50] records per page